Yaohe Wang

5.6k total citations
130 papers, 4.3k citations indexed

About

Yaohe Wang is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Yaohe Wang has authored 130 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Genetics, 62 papers in Oncology and 59 papers in Molecular Biology. Recurrent topics in Yaohe Wang's work include Virus-based gene therapy research (69 papers), CAR-T cell therapy research (51 papers) and Cancer Research and Treatments (28 papers). Yaohe Wang is often cited by papers focused on Virus-based gene therapy research (69 papers), CAR-T cell therapy research (51 papers) and Cancer Research and Treatments (28 papers). Yaohe Wang collaborates with scholars based in United Kingdom, China and United States. Yaohe Wang's co-authors include Nicholas R. Lemoine, David H. Kirn, Louisa S. Chard, Giulia Marelli, M. S. Ferguson, Ming Yuan, Gunnel Halldén, Jennelle Francis, John C. Bell and Han Hsi Wong and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yaohe Wang

128 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaohe Wang United Kingdom 36 2.4k 2.1k 2.0k 792 702 130 4.3k
Vincenzo Cerullo Finland 40 2.7k 1.1× 2.4k 1.1× 2.3k 1.1× 1.1k 1.3× 714 1.0× 139 4.7k
Karin Jooss United States 37 2.5k 1.0× 2.4k 1.2× 3.2k 1.6× 1.7k 2.2× 259 0.4× 74 5.8k
Yong Yu China 36 1.6k 0.7× 1.1k 0.5× 1.6k 0.8× 445 0.6× 987 1.4× 124 3.9k
Rob C. Hoeben Netherlands 48 3.8k 1.5× 1.7k 0.8× 4.0k 2.0× 1.3k 1.6× 433 0.6× 208 7.6k
Fabrice Le Bœuf Canada 25 1.2k 0.5× 1.0k 0.5× 1.6k 0.8× 502 0.6× 262 0.4× 38 3.0k
Kenzaburo Tani Japan 38 1.1k 0.5× 1.2k 0.6× 2.4k 1.2× 1.4k 1.8× 163 0.2× 225 5.4k
Justus B. Cohen United States 38 1.6k 0.6× 811 0.4× 2.1k 1.0× 794 1.0× 183 0.3× 142 4.4k
Jeong S. Hong United States 30 2.7k 1.1× 1.1k 0.5× 2.9k 1.5× 440 0.6× 214 0.3× 65 5.5k
Gloria González‐Aseguinolaza Spain 35 1.2k 0.5× 865 0.4× 1.9k 1.0× 1.7k 2.2× 107 0.2× 151 4.8k
Richard G. Carroll United States 45 1.5k 0.6× 3.5k 1.7× 2.5k 1.2× 3.4k 4.3× 215 0.3× 68 7.6k

Countries citing papers authored by Yaohe Wang

Since Specialization
Citations

This map shows the geographic impact of Yaohe Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaohe Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaohe Wang more than expected).

Fields of papers citing papers by Yaohe Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaohe Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaohe Wang. The network helps show where Yaohe Wang may publish in the future.

Co-authorship network of co-authors of Yaohe Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yaohe Wang. A scholar is included among the top collaborators of Yaohe Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaohe Wang. Yaohe Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xin, Sven Borchmann, Zhenguo Cheng, et al.. (2025). Bispecific Nanosystems Enable Multieffector Immune Cell Retargeting for Hematologic Malignancy Therapy. Advanced Science. 12(39). e09103–e09103.
2.
Wang, Rui, Lihong Wang, Zhe Zhang, et al.. (2025). Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancer. Journal for ImmunoTherapy of Cancer. 13(5). e010341–e010341. 2 indexed citations
3.
Wang, Rui, Hao Dun, Lihua Xu, et al.. (2025). Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer. Biomedicines. 13(4). 882–882. 1 indexed citations
4.
Chen, Xu, Liting Chen, Guangna Liu, et al.. (2025). Tailoring an intravenously injectable oncolytic virus for augmenting radiotherapy. Cell Reports Medicine. 6(5). 102078–102078. 4 indexed citations
5.
Chen, Lijuan, Pengju Wang, Zhe Zhang, et al.. (2025). A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer. Frontiers in Immunology. 15. 1492464–1492464. 4 indexed citations
6.
Guo, Yuduo, Weihai Ning, Yujia Chen, et al.. (2023). Oncolytic virus Ad-TD-nsIL-12 inhibits glioma growth and reprograms the tumor immune microenvironment. Life Sciences. 336. 122254–122254. 7 indexed citations
7.
Wang, Lihong, Yangyang Wu, Jingjing Wang, et al.. (2023). A novel microenvironment regulated system CAR-T (MRS.CAR-T) for immunotherapeutic treatment of esophageal squamous carcinoma. Cancer Letters. 568. 216303–216303. 7 indexed citations
8.
Wang, Yanru, et al.. (2023). Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy. Frontiers in Immunology. 14. 1126969–1126969. 12 indexed citations
9.
Baleeiro, Renato B., Peng Liu, Louisa S. Chard, et al.. (2022). MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy. OncoImmunology. 11(1). 2080329–2080329. 21 indexed citations
10.
Marelli, Giulia, Louisa S. Chard, Ming Yuan, et al.. (2021). A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer. Journal for ImmunoTherapy of Cancer. 9(1). e001624–e001624. 30 indexed citations
11.
Zhang, Yong, et al.. (2020). CircNOL10 Acts as a Sponge of miR-135a/b-5p in Suppressing Colorectal Cancer Progression via Regulating KLF9. SHILAP Revista de lepidopterología. 2 indexed citations
12.
Zhang, Li, Yaohe Wang, Chao Zhao, et al.. (2019). High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Chen, Sheng, Yanhong Liu, Yaohe Wang, & Xue Zhang. (2019). LncRNA CCAT1 Promotes Colorectal Cancer Tumorigenesis Via A miR-181b-5p/TUSC3 Axis. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Yuan, Ming, et al.. (2016). CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses. Viruses. 8(3). 72–72. 34 indexed citations
16.
Tookman, Laura A., Russell D. Bouwman, Katrina Pirlo, et al.. (2015). Pharmacological Inhibition of β3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity. Cancer Research. 75(14). 2811–2821. 12 indexed citations
17.
Chard, Louisa S., Eleni Maniati, Pengju Wang, et al.. (2014). A Vaccinia Virus Armed with Interleukin-10 Is a Promising Therapeutic Agent for Treatment of Murine Pancreatic Cancer. Clinical Cancer Research. 21(2). 405–416. 60 indexed citations
18.
Tysome, James R., Nicholas R. Lemoine, & Yaohe Wang. (2013). Update on oncolytic viral therapy – targeting angiogenesis. OncoTargets and Therapy. 6. 1031–1031. 21 indexed citations
19.
Tysome, James R., Xiaozhu Li, Shengdian Wang, et al.. (2012). A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity. Clinical Cancer Research. 18(24). 6679–6689. 56 indexed citations
20.
Wang, Yaohe, Rathi Gangeswaran, Pengju Wang, et al.. (2009). CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. Journal of Clinical Investigation. 119(6). 1604–1615. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026